Thyroid cytology and the risk of malignancy in thyroid nodules: importance of nuclear atypia in indeterminate specimens.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMID 11327619)

Published in Thyroid on March 01, 2001

Authors

A S Kelman1, A Rathan, J Leibowitz, D E Burstein, R S Haber

Author Affiliations

1: Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA.

Articles citing this

Implications of follicular neoplasms, atypia, and lesions suspicious for malignancy diagnosed by fine-needle aspiration of thyroid nodules. Ann Surg (2002) 1.32

Identification of genes differentially expressed in benign versus malignant thyroid tumors. Clin Cancer Res (2008) 1.05

Thyroid nodule management: clinical, ultrasound and cytopathological parameters for predicting malignancy. Clinics (Sao Paulo) (2012) 0.86

Malignancy risk analysis in patients with inadequate fine needle aspiration cytology (FNAC) of the thyroid. PLoS One (2012) 0.86

Learning curve for endoscopic thyroidectomy: a single teaching hospital study. Onco Targets Ther (2013) 0.84

Current surgical status of thyroid diseases. J Multidiscip Healthc (2011) 0.81

Predictive value of cytologic atypia in indeterminate thyroid fine-needle aspirate biopsies. Ann Surg Oncol (2011) 0.81

The clinical significance of atypia in thyroid fine-needle aspiration. Eur Arch Otorhinolaryngol (2007) 0.80

The predictive value of dominant nodules and the management of indeterminate group in multinodular goiter. Eur Arch Otorhinolaryngol (2011) 0.78

Multi-institutional validation of a novel textural analysis tool for preoperative stratification of suspected thyroid tumors on diffusion-weighted MRI. Magn Reson Med (2015) 0.77

Distinguishing molecular markers in thyroid tumors: a tribute to Dr. Orlo Clark. World J Surg (2009) 0.77

Subclassification of the "grey zone" of thyroid cytology; a retrospective descriptive study with clinical, cytological, and histological correlation. J Thyroid Res (2011) 0.77

Subclassification of follicular neoplasms recommended by the Japan thyroid association reporting system of thyroid cytology. Int J Endocrinol (2015) 0.75

Clinicopathological factors increased the risk of malignancy in thyroid nodules with atypical or follicular lesions of undetermined significance (AUS/FLUS) risk factor of malignancy in thyroid nodule with AUS/FLUS. Ann Surg Treat Res (2016) 0.75

Identification of benign and malignant thyroid nodules by in vivo iodine concentration measurement using single-source dual energy CT: A retrospective diagnostic accuracy study. Medicine (Baltimore) (2016) 0.75

Cytomorphologic features distinguishing Bethesda category IV thyroid lesions from parathyroid. Cytojournal (2017) 0.75

Articles by these authors

Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region. J Exp Med (1986) 2.18

Evidence for RNA synthesis-dependent and -independent pathways in stimulation of neurite outgrowth by nerve growth factor. Proc Natl Acad Sci U S A (1978) 2.00

Abrogation of resistance to Theiler's virus-induced demyelination in H-2b mice deficient in beta 2-microglobulin. J Immunol (1993) 1.85

GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis. Cancer (1998) 1.68

Theiler's murine encephalomyelitis: a model of demyelination and persistence of virus. Crit Rev Immunol (1987) 1.65

Recombinants of Mahoney and Sabin strain poliovirus type 1: analysis of in vitro phenotypic markers and evidence that resistance to guanidine maps in the nonstructural proteins. Virology (1984) 1.60

Immunohistochemical localization of basic fibroblast growth factor in astrocytomas. Cancer Res (1990) 1.59

Haemolysis and fixation of erythrocytes by X-rays. Biochem J (1947) 1.58

Partial suppression of Theiler's virus-induced demyelination in vivo by administration of monoclonal antibodies to immune-response gene products (Ia antigens). Neurology (1986) 1.55

Caloric intake in a group of peritoneal dialysis patients. Am J Kidney Dis (1998) 1.38

Fine needle aspiration biopsy diagnosis of tuberculous lymphadenitis in patients with and without the acquired immune deficiency syndrome. Acta Cytol (1991) 1.35

The role of transcription-dependent priming in nerve growth factor promoted neurite outgrowth. Dev Biol (1982) 1.31

Activated N-ras gene induces neuronal differentiation of PC12 rat pheochromocytoma cells. J Cell Physiol (1986) 1.27

CD4(+) and CD8(+) T cells make discrete contributions to demyelination and neurologic disease in a viral model of multiple sclerosis. J Virol (1998) 1.27

Theiler's virus persistence and demyelination in major histocompatibility complex class II-deficient mice. J Virol (1996) 1.23

Perforin-dependent neurologic injury in a viral model of multiple sclerosis. J Neurosci (1998) 1.21

Glucocorticoid-induced insulin resistance: dexamethasone inhibits the activation of glucose transport in rat skeletal muscle by both insulin- and non-insulin-related stimuli. Diabetes (1995) 1.13

The human blood-brain barrier glucose transporter (GLUT1) is a glucose transporter of gray matter astrocytes. Glia (1995) 1.13

Molecular and functional analysis of the human prothrombinase gene (HFGL2) and its role in viral hepatitis. Am J Pathol (2000) 1.13

Nerve growth factor has both mitogenic and antimitogenic activity. Dev Biol (1982) 1.09

Synthesis and assembly of adenovirus polypeptides. III. Reversible inhibition of hexon assembly in adenovirus type 5 temperature-sensitive mutants. Virology (1975) 1.09

Fulminant hepatic failure in murine hepatitis virus strain 3 infection: tissue-specific expression of a novel fgl2 prothrombinase. J Virol (1997) 1.08

Dissociation of c-fos from ODC expression and neuronal differentiation in a PC12 subline stably transfected with an inducible N-ras oncogene. Biochem Biophys Res Commun (1988) 1.03

Lithium ion inhibits nerve growth factor-induced neurite outgrowth and phosphorylation of nerve growth factor-modulated microtubule-associated proteins. J Cell Biol (1985) 1.03

Monoclonal antibody analysis of a unique macrophage procoagulant activity induced by murine hepatitis virus strain 3 infection. J Biol Chem (1991) 1.01

Regulation of GLUT2 glucose transporter expression in liver by thyroid hormone: evidence for hormonal regulation of the hepatic glucose transport system. Endocrinology (1994) 1.00

Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes. Am J Physiol (1993) 0.99

The nucleocapsid protein of murine hepatitis virus type 3 induces transcription of the novel fgl2 prothrombinase gene. J Biol Chem (1999) 0.99

Immunohistochemical staining of GLUT1 in benign, hyperplastic, and malignant endometrial epithelia. Cancer (2000) 0.97

Synaptophysin: a sensitive and specific marker for ganglion cells in central nervous system neoplasms. Hum Pathol (1990) 0.96

Thyroid hormone increases muscle/fat glucose transporter gene expression in rat skeletal muscle. Endocrinology (1991) 0.95

Spontaneous CNS remyelination in beta 2 microglobulin-deficient mice following virus-induced demyelination. J Neurosci (1995) 0.94

Thyroid hormone increases basal and insulin-stimulated glucose transport in skeletal muscle. The role of GLUT4 glucose transporter expression. Diabetes (1994) 0.94

GLUT1 glucose transporter expression in benign and malignant thyroid nodules. Thyroid (1997) 0.93

Fine needle aspiration biopsy of cystic benign lymphoepithelial lesion of the parotid gland in patients at risk for the acquired immune deficiency syndrome. Acta Cytol (1991) 0.93

Effects of thiazolidinediones on glucocorticoid-induced insulin resistance and GLUT4 glucose transporter expression in rat skeletal muscle. Metabolism (1993) 0.92

Nerve growth factor-induced neuronal differentiation of PC12 pheochromocytoma cells: lack of inhibition by a tumor promoter. Brain Res (1982) 0.91

Stimulation of Na,K-activated adenosine triphosphatase and active transport by low external K+ in a rat liver cell line. J Gen Physiol (1986) 0.90

Ionic dependence of active Na-K transport: "clamping" of cellular Na+ with monensin. Am J Physiol (1987) 0.88

Early enhancement of passive potassium efflux from rat liver by thyroid hormone: relation to induction of Na,K-ATPase. Endocrinology (1984) 0.87

GLUT1 glucose transporter: a highly sensitive marker of malignancy in body cavity effusions. Mod Pathol (1998) 0.84

Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection. Adv Exp Med Biol (1998) 0.84

Citrullinemia. Virchows Arch A Pathol Anat Histol (1978) 0.84

A monoclonal natural autoantibody that promotes remyelination suppresses central nervous system inflammation and increases virus expression after Theiler's virus-induced demyelination. Int Immunol (1996) 0.83

A Th1 cell line (3E9.1) from resistant A/J mice inhibits induction of macrophage procoagulant activity in vitro and protects against MHV-3 mortality in vivo. Immunology (1994) 0.83

Stimulation of glucose transport by thyroid hormone in ARL 15 cells: increased abundance of glucose transporter protein and messenger ribonucleic acid. Endocrinology (1990) 0.82

Oncogene N-ras mediates selective inhibition of c-fos induction by nerve growth factor and basic fibroblast growth factor in a PC12 cell line. Mol Cell Biol (1990) 0.82

Mouse hepatitis virus-3 induced prothrombinase (Fgl2) maps to proximal chromosome 5. Genomics (1995) 0.81

Fine-needle aspiration diagnosis of synovial chondromatosis of the tibiofibular joint. Ann Diagn Pathol (2000) 0.81

Benign neonatal hemangiomatosis: review and description of a patient with unusually persistent lesions. Pediatr Dermatol (1990) 0.80

Cellular and metabolic requirements for induction of macrophage procoagulant activity by murine hepatitis virus strain 3 in vitro. J Immunol (1991) 0.80

Effect of 3,5,3'-triiodothyronine treatment on potassium efflux from isolated rat diaphragm: role of increased permeability in the thermogenic response. Endocrinology (1982) 0.80

Reproducibility and accuracy of interactive segmentation procedures for image analysis in cytology. J Microsc (1997) 0.80

Stimulation of potassium efflux in rat liver by a low dose of thyroid hormone: evidence for enhanced cation permeability in the absence of Na,K-ATPase induction. Endocrinology (1986) 0.80

Synaptophysin: a sensitive and specific marker for ganglion cells in central nervous system neoplasms. Hum Pathol (1990) 0.80

Regulation of protein kinase C activity in neuronal differentiation induced by the N-ras oncogene in PC-12 cells. Mol Cell Biol (1990) 0.80

Loss of resistance to murine hepatitis virus strain 3 infection after treatment with corticosteroids is associated with induction of macrophage procoagulant activity. J Virol (1996) 0.79

Value of GCDFP-15 (BRST-2) as a specific immunocytochemical marker for breast carcinoma in cytologic specimens. Acta Cytol (1996) 0.79

Potentiation of oncogenic N-ras-induced neurite outgrowth and ornithine decarboxylase activity by phorbol dibutyrate and protein kinase inhibitor H-8. J Cell Physiol (1990) 0.79

The concentration dependence of active K+ transport in the turkey erythrocyte. Hill analysis and evidence for positive cooperativity between ion binding sites. J Gen Physiol (1983) 0.79

Kinetic analysis of Na,K-activated adenosine triphosphatase induced by low external K+ in a rat liver cell line. J Biol Chem (1988) 0.79

The diagnosis of recurrent thyroid cancer--a new approach. J Clin Endocrinol Metab (1998) 0.79

Synthesis and assembly of adenovirus type 2 polypeptides. II. Reversible inhibition of hexon assembly at 42 degrees. Virology (1974) 0.78

GLUT1 and p63 expression in endometrial intraepithelial and uterine serous papillary carcinoma. Histopathology (2006) 0.78

Feasibility of immunocytochemical detection of tumor markers (XIAP, phosphohistone H1 and p63) in FNA cellblock samples from head and neck squamous cell carcinoma. Diagn Cytopathol (2008) 0.78

Stimulation of active Na+ and K+ transport by thyroid hormone in a rat liver cell line: role of enhanced Na+ entry. Endocrinology (1986) 0.77

Genomic and non-genomic actions of nerve growth factor in development. Prog Brain Res (1983) 0.77

Glucose transport stimulation by thyroid hormone in ARL 15 cells: partial role of increased GLUT1 glucose transporter gene transcription. Thyroid (1993) 0.77

Differential regulation of glucose transporter isoforms by thyroid hormone in rat heart. Biochim Biophys Acta (1992) 0.77

Toxic shock syndrome following influenza A in a child. Crit Care Med (1991) 0.76

Defective infection of rabbit peripheral blood monocyte cultures with human immunodeficiency virus type 1. AIDS Res Hum Retroviruses (1994) 0.76

Thyroid hormone and Na,K transport. Trans Am Clin Climatol Assoc (1987) 0.75

Psoriasis and Reiter's syndrome. Clin Dermatol (1991) 0.75

[Human values and medical ethics]. Harefuah (1990) 0.75

Role of macrophage procoagulant activity in mouse hepatitis virus (MHV) infection: studies using T cell MHV-3 clones and monoclonal antibody 3D4.3. Adv Exp Med Biol (1993) 0.75

Comparison of biological and behavioral activities of alpha- and gamma-melanocyte stimulating hormones. Peptides (1981) 0.75

A community mental health team to serve revolving door patients. The Doddington Edward Wilson (DEW) Mental Health Team 1984-1988. Int J Soc Psychiatry (1990) 0.75

Leporine acquired immune deficiency disease. Symp Fundam Cancer Res (1986) 0.75

Cytologic findings in the differential diagnosis of C-cell hyperplasia and medullary carcinoma by fine needle aspiration. A case report. Acta Cytol (1998) 0.75

Milk-coagulation and proteolysis. I. Enzymologia (1966) 0.75

Immunocytochemical detection of cyclin, a proliferation-associated protein, in cytologic preparations. Acta Cytol (1991) 0.75

Cytologic findings in progressive multifocal leukoencephalopathy. Report of two cases. Acta Cytol (1987) 0.75

Cytology of extrapulmonary Pneumocystis carinii infection in the acquired immunodeficiency syndrome. Acta Cytol (1992) 0.75

Novel histiocytoses considered in the context of histiocyte subset differentiation. Arch Dermatol (1993) 0.75

The future of topical therapy for cutaneous aging. J Dermatol Surg Oncol (1990) 0.75